Skip to Content

Health

Racial, economic barriers hinder access to opioid use disorder medication, OSU, Johns Hopkins scientists say

PORTLAND, Ore. (KTVZ) – Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community that’s racially and economically segregated, according to a new study led by scientists at Oregon State University and Johns Hopkins University. The findings shed additional light

Continue Reading

Common respiratory virus that dwindled during the pandemic is on the rise, CDC warns, with higher risk for certain groups

By Katherine Dillinger, CNN (CNN) — A seasonal respiratory virus named parvovirus B19 – sometimes also called fifth disease – is increasing in activity, the US Centers for Disease Control and Prevention warned Tuesday. Parvovirus B19 is a common virus spread by respiratory droplets. Antibodies from infection are believed to help protect against reinfection, the

Continue Reading

FDA rejection of MDMA-assisted therapy rattles advocates but doesn’t spell end of psychedelics in medicine, experts say

By Deidre McPhillips and Carma Hassan, CNN (CNN) — The path toward federal approval for medical treatments involving psychedelics may be longer and less straightforward after the US Food and Drug Administration denied the first application for a treatment in this category, but experts say the work is far from over. On Friday, the FDA

Continue Reading